Beijing Konruns Pharmaceutical Co.,Ltd. 603590.SS Stock
Beijing Konruns Pharmaceutical Co.,Ltd. Price Chart
Beijing Konruns Pharmaceutical Co.,Ltd. 603590.SS Financial and Trading Overview
Contents
| Beijing Konruns Pharmaceutical Co.,Ltd. stock price | 28.59 CNY |
| Previous Close | 30.9 CNY |
| Open | 31.2 CNY |
| Bid | 31.07 CNY x 0 |
| Ask | 31.08 CNY x 0 |
| Day's Range | 30.3 - 31.51 CNY |
| 52 Week Range | 21.95 - 40.65 CNY |
| Volume | 1.64M CNY |
| Avg. Volume | 1.94M CNY |
| Market Cap | 4.97B CNY |
| Beta (5Y Monthly) | 0.355533 |
| PE Ratio (TTM) | 60.941177 |
| EPS (TTM) | 0.94 CNY |
| Forward Dividend & Yield | 0.3 (0.96%) |
| Ex-Dividend Date | June 29, 2022 |
| 1y Target Est | 44.55 CNY |
603590.SS Valuation Measures
| Enterprise Value | 4.54B CNY |
| Trailing P/E | 60.941177 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.679046 |
| Price/Book (mrq) | 1.6036323 |
| Enterprise Value/Revenue | 5.189 |
| Enterprise Value/EBITDA | 30.313 |
Trading Information
Beijing Konruns Pharmaceutical Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.355533 |
| 52-Week Change | 18.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 40.65 CNY |
| 52 Week Low | 21.95 CNY |
| 50-Day Moving Average | 35.85 CNY |
| 200-Day Moving Average | 29.15 CNY |
603590.SS Share Statistics
| Avg. Volume (3 month) | 1.94M CNY |
| Avg. Daily Volume (10-Days) | 2.06M CNY |
| Shares Outstanding | 160M |
| Float | 61.32M |
| Short Ratio | N/A |
| % Held by Insiders | 53.77% |
| % Held by Institutions | 0.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.64% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.5882 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 9.21% |
| Operating Margin (ttm) | 13.88% |
| Gross Margin | 85.95% |
| EBITDA Margin | 17.11% |
Management Effectiveness
| Return on Assets (ttm) | 2.18% |
| Return on Equity (ttm) | 3.19% |
Income Statement
| Revenue (ttm) | 875.64M CNY |
| Revenue Per Share (ttm) | 5.56 CNY |
| Quarterly Revenue Growth (yoy) | 5.70% |
| Gross Profit (ttm) | 740.07M CNY |
| EBITDA | 149.89M CNY |
| Net Income Avi to Common (ttm) | 80.72M CNY |
| Diluted EPS (ttm) | 0.51 |
| Quarterly Earnings Growth (yoy) | -44.70% |
Balance Sheet
| Total Cash (mrq) | 650.53M CNY |
| Total Cash Per Share (mrq) | 4.16 CNY |
| Total Debt (mrq) | 90.16M CNY |
| Total Debt/Equity (mrq) | 2.73 CNY |
| Current Ratio (mrq) | 7.224 |
| Book Value Per Share (mrq) | 19.381 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 77.4M CNY |
| Levered Free Cash Flow (ttm) | -239649760 CNY |
Profile of Beijing Konruns Pharmaceutical Co.,Ltd.
| Country | China |
| State | N/A |
| City | Beijing |
| Address | Building 3 |
| ZIP | 102206 |
| Phone | 86 10 8289 8888 |
| Website | https://www.konruns.cn |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 449 |
Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of special drugs in China. The company offers agkistrodon acutus hemocoagulase under Suling trade name in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It is also involved in the development of drug candidates, including CX1026, CX1003, and KC1036. Beijing Konruns Pharmaceutical Co.,Ltd. was founded in 2003 and is headquartered in Beijing, China.
Q&A For Beijing Konruns Pharmaceutical Co.,Ltd. Stock
What is a current 603590.SS stock price?
Beijing Konruns Pharmaceutical Co.,Ltd. 603590.SS stock price today per share is 28.59 CNY.
How to purchase Beijing Konruns Pharmaceutical Co.,Ltd. stock?
You can buy 603590.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Beijing Konruns Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Beijing Konruns Pharmaceutical Co.,Ltd. is 603590.SS.
Which industry does the Beijing Konruns Pharmaceutical Co.,Ltd. company belong to?
The Beijing Konruns Pharmaceutical Co.,Ltd. industry is Biotechnology.
How many shares does Beijing Konruns Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Beijing Konruns Pharmaceutical Co.,Ltd. shares is 160M.
What is Beijing Konruns Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Beijing Konruns Pharmaceutical Co.,Ltd. PE Ratio is 30.41489400 now.
What was Beijing Konruns Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Beijing Konruns Pharmaceutical Co.,Ltd. EPS is 0.94 CNY over the trailing 12 months.
Which sector does the Beijing Konruns Pharmaceutical Co.,Ltd. company belong to?
The Beijing Konruns Pharmaceutical Co.,Ltd. sector is Healthcare.